CEB8: A DECISION ANALYTIC MODEL MEASURING THE COST-EFFECTIVENESS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN HIV+ PATIENTS WITH HIGH VERSUS LOW BASELINE VIRAL LOAD: AN INDINAVIR PLUS LAMIVUDINE ANDZIDOVUDINE EXAMPLE

Authors :: A Rachlis
M Doswell
M Bast
NA Risebrough
D McMurchy
P Oh
Source :: Value in Health. (2):67
Publisher :: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Subjects :: medicine.medical_specialty
Cost effectiveness
business.industry
Health Policy
Analytic model
Public Health, Environmental and Occupational Health
Lamivudine
Virology
Antiretroviral therapy
Indinavir
Internal medicine
medicine
Hiv patients
Baseline (configuration management)
business
Viral load
medicine.drug

Full Text Access

Tools